← The Wire
TARANasdaq
Protara Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · CIK 1359931
Advancing transformative cell therapies and phospholipid substrate replacement therapies for cancer and rare diseases
red 8-K · 90d
$219M
Market cap
$4.16
Last close
+1.0%
1D
+1.2%
5D
989K
Volume
Price · last 39 sessions-23.7%
May 4L $3.65 · H $5.66Jun 29
244
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 28, 2026DEFA14AADDITIONAL MATERIALSApr 25, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 27, 2022DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 27, 2021DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 23, 2020DEFA14AFORM 8-KJun 23, 2017DEFA14AFORM 8-KJun 22, 2017
Similar companies
Comparable business profile · signals at a glance